FundedIQ

Recently Funded Biotechnology Startups in New York

Updated Sep 2026

Funded Biotechnology startups in New York number 126 in FundedIQ, tracked with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in New York, along with the 100 most recently funded Biotechnology startups in New York.

Biotechnology startups in New York closed 67 funding rounds over the last 24 months, 35 of them in the last 12 months, and raised $3.9B in disclosed capital. The median disclosed round is $12M, with the middle half of rounds falling between $3.3M and $50M.

New York biotechnology activity centers on early stage ventures. Seed and Series A companies dominate the group, meaning the market consists of teams validating hypotheses and building initial prototypes. Sourcing focuses on raw potential rather than scaled operations. These firms lack deep commercial histories, creating a high volume of fresh leads for those targeting nascent technology.

Biotechnology funded startup statistics in New York

Funded Biotechnology startups in New York
126
tracked in the database
Funding rounds, last 12 months
35
67 over 24 months
Disclosed capital raised, 24 months
$3.9B
59 of 67 rounds disclosed an amount
Median round size
$12M
middle half $3.3M to $50M

Most recent funding round on record: Jul 2026.

100 most recently funded Biotechnology startups in New York

100 of 126

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

R
New York, United States · Biotechnology
Reme-D is a cutting-edge technology company that has patented technology, which is revolutionizing healthcare…
Seed ·
$1.4M
N
New York, United States · Biotechnology
Series Unknown ·
$250M
A
ARMR Sciences
New York, United States · Biotechnology
ARMR Sciences develops immunotherapy-based biodefense solutions to prevent overdose from fentanyl and…
Series Unknown ·
Undisclosed
D
New York, United States · Biotechnology
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and…
Series Unknown ·
$805M
N
National Kidney Foundation
New York, United States · Biotechnology
National Kidney Foundation is a voluntary health organization. Pioneers of scientific research and…
Series Unknown ·
Undisclosed
B
New York, United States · Biotechnology
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for…
Series Unknown ·
$4.7M
W
New York, United States · Biotechnology
Optimizing cell therapy with spatial biology
Series A ·
$20M
B
New York, United States · Biotechnology
BrainStorm Cell Therapeutics is a biotechnology company that is focused on developing advanced stem cell…
Series Unknown ·
$400k
E
New York, United States · Biotechnology
Eyenovia is a biopharmaceutical company that provides portfolio of next generation topical eye treatments. It…
Series Unknown ·
$10M
R
New York, United States · Biotechnology
Renaissance Philanthropy is a nonprofit organization that provides philanthropic advisory, fund design, and…
Series Unknown ·
$533M
F
New York, United States · Biotechnology
Fathom Therapeutics, previously known as Atommap, is a biotechnology company focused on designing therapeutic…
Series A ·
$47M
M
New York, United States · Biotechnology
MeiraGTx is committed to the development and commercialization of innovative gene therapy products to…
Series Unknown ·
$100M
C
New York, United States · Biotechnology
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical…
Series D ·
$50M
S
New York, United States · Biotechnology
Sparian Biosciences is an early-stage CNS-focused biopharmaceutical firm focusing on creating unique,…
Series Unknown ·
$15M
B
New York, United States · Biotechnology
Bond Biosciences is a privately-held biopharmaceutical company focused on the discovery and development of…
Series Unknown ·
$5.3M
A
New York, United States · Biotechnology
Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It…
Series Unknown ·
$10M
H
New York, United States · Biotechnology
Hoth Therapeutics is a company that is currently in the clinical stage of development in the…
Series Unknown ·
$2.0M
G
New York, United States · Biotechnology
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of…
Series A ·
$60M
R
New York, United States · Biotechnology
Relmada Therapeutics is a late-stage biotechnology company addressing diseases of the central nervous system…
Series Unknown ·
$160M
P
New York, United States · Biotechnology
Prolium is a biotechnology company, which specializes in providing breakthrough therapies to the patients…
Series A ·
$50M
I
New York, United States · Biotechnology
Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies…
Series Unknown ·
$400M
I
New York, United States · Biotechnology
ILiAD Biotechnologies (ILiAD) is a clinical-stage biotechnology company focused on the prevention and…
Series D ·
$115M
L
New York, United States · Biotechnology
LB Pharmaceuticals is a company in the early stages of development in the field of life sciences. They are…
Series Unknown ·
$100M
D
New York, United States · Biotechnology
DAXOR Corporation is a groundbreaking medical technology company that has created the BVA-100 Blood Volume…
Series Unknown ·
$9.0M
T
New York, United States · Biotechnology
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and…
Series Unknown ·
$20M
I
New York, United States · Biotechnology
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and…
Series Unknown ·
$20M
M
New York, United States · Biotechnology
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Series A ·
$20M
P
New York, United States · Biotechnology
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients…
Series B ·
$78M
P
New York, United States · Biotechnology
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Venture - Series Unknown ·
Undisclosed
S
SleepSpace
New York, United States · Biotechnology
SleepSpace is an innovative Sleep Operating System that aims to connect all devices in a future smart…
Series Unknown ·
Undisclosed
V
New York, United States · Biotechnology
Volastra Therapeutics is a biotechnology company that is creating new treatments for metastatic cancer by…
Venture - Series Unknown ·
$30M
G
New York, United States · Biotechnology
Gameto is a biotechnology company focused on revolutionizing women's reproductive health through the…
Series C ·
$44M
E
New York, United States · Biotechnology
Eyenovia is a biopharmaceutical company founded in 2014 that offers a range of innovative topical eye…
Series Unknown ·
$50M
G
New York, United States · Biotechnology
GenKardia's goal is to provide new treatments that enhance the quality of life for individuals facing Heart…
Series Unknown ·
$250k
B
New York, United States · Biotechnology
BioVaxys Technology Corp. is a biotechnology company based in British Columbia that focuses on developing…
Series Unknown ·
$40k
M
New York, United States · Biotechnology
Mustang Bio is a biopharmaceutical company in the clinical stage that concentrates on obtaining, creating,…
Series Unknown ·
$8.0M
S
New York, United States · Biotechnology
Spine BioPharma develops a non-surgical solution for back pain that will eliminate pain and restore…
Series Unknown ·
$14M
B
New York, United States · Biotechnology
BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver…
Seed ·
$5.5M
T
New York, United States · Biotechnology
Tracer is a SaaS company that offers a platform to monitor and fix broken pipelines using a bioinformatics…
Seed ·
$2.9M
O
New York, United States · Biotechnology
OverT Bio is a biotech company that offers cell therapy for cancer. The company specializes in creating…
Series Unknown ·
$120k
N
Niura
New York, United States · Biotechnology
At Niura, we understand how valuable your time is. But in a world full of distractions, the minutes that slip…
Seed ·
Undisclosed
M
New York, United States · Biotechnology
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for…
Series B ·
$215M
N
New York, United States · Biotechnology
Neurogene is accelerating development of new genetic medicines to people with devastating neurological…
Series Unknown ·
$200M
C
New York, United States · Biotechnology
Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead…
Series Unknown ·
$3.5M
S
New York, United States · Biotechnology
Starton Therapeutics is a biotech firm with a goal to revolutionize therapeutic care. Their focus lies in…
Series Unknown ·
$2.1M
H
New York, United States · Biotechnology
Helaina is a biotechnology firm that creates baby formula similar to breast milk as an alternative. The…
Series B ·
$45M
P
Penelope Mimetics
New York, United States · Biotechnology
Penelope Mimetics is an innovative research and development company that uses nature's principles to inspire…
Pre-Seed ·
Undisclosed
L
New York, United States · Biotechnology
Levels created a health and wellness platform that focuses on tracking metabolic fitness by monitoring blood…
Series A ·
$10M
M
New York, United States · Biotechnology
MindMed offers treatments and therapies for substance abuse disorders and mental illnesses that are inspired…
Series Unknown ·
$75M
T
New York, United States · Biotechnology
TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition,…
Series Unknown ·
$250M
A
American Liver Foundation
New York, United States · Biotechnology
The goal of the American Liver Foundation is to assist, champion, and advance education, support, and…
Series Unknown ·
Undisclosed
R
New York, United States · Biotechnology
RenBio creates treatment options for cancer and inflammatory diseases using antibodies. The MYO technology,…
Series Unknown ·
$2.9M
C
New York, United States · Biotechnology
Clarapath is a medical robotics company that aims to automate laboratory processes. Their initial product…
Series B ·
$36M
L
New York, United States · Biotechnology
Established by a group of healthcare and fertility experts from Harvard, Legacy (YC S19) is revolutionizing…
Series Unknown ·
$7.5M
C
New York, United States · Biotechnology
Cell BioEngines, Inc. is a biotech company in the clinical stage that is dedicated to creating ready-to-use…
Pre-Seed ·
$250k
F
New York, United States · Biotechnology
Formation Bio is a biotechnology company that prioritizes drug development in order to deliver new treatments…
Series D ·
$372M
S
New York, United States · Biotechnology
Wearable neurotechnology that enhances vision, hearing, and touch
Seed ·
$50k
R
New York, United States · Biotechnology
Royalty Pharma has built a successful business in the biopharmaceutical industry by acquiring…
Series Unknown ·
$1.5B
M
Matter Bio
New York, United States · Biotechnology
Matter Bio is a company that focuses on protecting the integrity of genetic material.
Series Unknown ·
Undisclosed
D
New York, United States · Biotechnology
The Definitive Diagnostics platform is able to detect the most common types of cancer, such as breast, lung,…
Seed ·
$100k
O
New York, United States · Biotechnology
Oculogica is a company that focuses on creating medical devices for neuro-diagnostic purposes, specifically…
Series Unknown ·
$7.6M
A
New York, United States · Biotechnology
Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases…
Series Unknown ·
$75M
T
Traverse Biotech
New York, United States · Biotechnology
Traverse Biotech is a privately owned biotech company that specializes in advancing immunotherapy products in…
Series Unknown ·
Undisclosed
A
New York, United States · Biotechnology
Arcade Therapeutics uses breakthrough neuroscientific research to improve mental health through casual,…
Seed ·
$1.5M
B
Branching Minds
New York, United States · Biotechnology
Branching Minds solves a large and growing problem for teachers, principals and superintendents: educators…
Series Unknown ·
Undisclosed
C
New York, United States · Biotechnology
C16 Biosciences was established in 2017 with the objective of utilizing microbiology to create sustainable…
Series Unknown ·
$1.0M
E
New York, United States · Biotechnology
The company Establishment Labs is focused on medical technology and is known for its innovation. They design,…
Series Unknown ·
$50M
O
New York, United States · Biotechnology
OnCusp Therapeutics, founded by Bing Yuan, Eric Slosberg, and Andy Fu, is a biopharmaceutical company that…
Series A ·
$100M
G
Graviton Bioscience
New York, United States · Biotechnology
Graviton Bioscience is a company in the stage of clinical drug exploration and development, with a primary…
Seed ·
Undisclosed
M
Medicovestor
New York, United States · Biotechnology
Unleashing the Power of Antibodies to Fight Cancer: We aim to unlock the full potential of antibodies and…
Seed ·
Undisclosed
T
New York, United States · Biotechnology
We are plastic-free and 100% naturally biodegradable alternative to synthetic and animal leathers. TômTex is…
Seed ·
$2.3M
F
New York, United States · Biotechnology
Fortress Biotech, Inc. is a biopharmaceutical company that has been recognized for its rapid growth in the…
Series Unknown ·
$10M
T
New York, United States · Biotechnology
Tourmaline Bio is a biomedical firm that is dedicated to creating groundbreaking medications that can…
Series Unknown ·
$75M
I
New York, United States · Biotechnology
Intelligent Bio Solutions effectively utilizes technology to create innovative and precise solutions that…
Series Unknown ·
$4.0M
B
New York, United States · Biotechnology
The Breast Cancer Research Foundation is dedicated to the goal of preventing and finding a cure for breast…
Series Unknown ·
$17M
O
New York, United States · Biotechnology
Oramed Pharmaceuticals (NASDAQCM:ORMP) was established in 2006 and is based on extensive medical research…
Series Unknown ·
$102M
C
New York, United States · Biotechnology
Calder is a clinical-manufacturing stage biotechnology company producing next-generation vaccines that elicit…
Seed ·
$530k
N
New York, United States · Biotechnology
Nine Square Therapeutics, based in New York, is a company established in 2020 that focuses on the development…
Series Unknown ·
$4.5M
D
New York, United States · Biotechnology
Delcath Systems specializes in the treatment of metastatic liver cancer through interventional oncology.…
Series Unknown ·
$35M
C
New York, United States · Biotechnology
Ceramedix Holding is a company specializing in biotherapeutics, dedicated to creating medication using…
Series Unknown ·
$3.0M
I
New York, United States · Biotechnology
Intelligent Bio Solutions aims to revolutionize the testing process by providing convenient, painless…
Series Unknown ·
$1.4M
H
New York, United States · Biotechnology
Helocyte Inc., a company owned by Fortress Biotech, has a focus on developing and selling new immunotherapies…
Series Unknown ·
$3.2M
E
New York, United States · Biotechnology
Height Oncology makes genomic tests noteworthy by specifically creating medications to hinder the particular…
Series Unknown ·
$50M
K
New York, United States · Biotechnology
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Series Unknown ·
$8.2M
D
Dante Labs
New York, United States · Biotechnology
Dante Labs is a genetic testing and data analysis company specialized in Whole Genome Sequencing. Our mission…
Series Unknown ·
Undisclosed
G
New York, United States · Biotechnology
We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of…
Series Unknown ·
$100k
O
Olatec Therapeutics
New York, United States · Biotechnology
Olatec is a company in the field of biopharmaceuticals that operates privately and specializes in creating a…
Series Unknown ·
Undisclosed
R
New York, United States · Biotechnology
With the speedy delivery of cutting-edge treatments and technologies to patients, Roivant seeks to improve…
Series Unknown ·
$200M
A
New York, United States · Biotechnology
Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of…
Series Unknown ·
$15M
E
New York, United States · Biotechnology
Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.…
Series Unknown ·
$6.0M
T
TMRW Life Sciences
New York, United States · Biotechnology
TMRW safeguards the world’s most precious cells for life. The TMRW platform revolutionizes the management,…
Series Unknown ·
Undisclosed
S
New York, United States · Biotechnology
Bryostatin-1 and its analogs are being used by clinical-stage biotech business Synaptogenix to find and…
Series Unknown ·
$15M
C
New York, United States · Biotechnology
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and…
Venture - Series Unknown ·
Undisclosed
S
New York, United States · Biotechnology
Pre-Seed ·
$6.3M
S
New York, United States · Biotechnology
Grant ·
$910k
E
New York, United States · Biotechnology
Grant ·
$40k
I
New York, United States · Biotechnology
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with…
Post-IPO Equity ·
$75M
L
New York, United States · Biotechnology
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing…
Series D ·
$20M
O
New York, United States · Biotechnology
We're developing technologies to replicate cancer patients' disease ex-vivo to rapidly and accurately test a…
Seed ·
$3.3M
N
New York, United States · Biotechnology
Core gives hereditary examination of more noteworthy broadness, profundity, and excellence. Clients can…
Seed ·
$14M

26 more funded startups

126 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Jul 2022). The full 126-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 126 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Funding stages of funded Biotechnology startups in New York

How the last 24 months of funding rounds for funded Biotechnology startups in New York break down by stage.

A further 48 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in New York

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 126 funded Biotechnology startups in New York currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (8 of 67 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in New York is dated Jul 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in New York?

FundedIQ tracks 126 funded Biotechnology startups in New York. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in New York raised?

Biotechnology startups in New York tracked by FundedIQ have raised $3.9B in disclosed capital across 67 funding rounds over the last 24 months, including 35 rounds in the last 12 months. 59 of those 67 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in New York?

The median disclosed round over the last 24 months is $12M, and the middle half of rounds fall between $3.3M and $50M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in New York?

Seed is the most common labelled stage, with 5 rounds in the last 24 months, ahead of Series A (5) and Series B (3). A further 48 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in New York updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in New York is dated Jul 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.